Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cochlear ( (AU:COH) ) has issued an announcement.
The Bank of New York Mellon Corporation and its related group entities have notified Cochlear Ltd that they have ceased to be substantial shareholders in the company as of 27 April 2026. The change reflects a reduction in BNY Mellon’s relevant interest and voting power in Cochlear, potentially altering the company’s institutional shareholder mix and slightly reshaping the profile of its international investor base.
The notice confirms that all relevant group entities associated with BNY Mellon are treated as associates under Australian corporations law due to common ownership and control. While no detailed transaction data is disclosed in the summary, the filing signals an exit below the substantial holding threshold by a major U.S.-based custodian and asset servicing institution, which may marginally impact perceptions of overseas institutional support for Cochlear shares.
The most recent analyst rating on (AU:COH) stock is a Hold with a A$111.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Ltd is a medical device company specialising in implantable hearing solutions, including cochlear implants and related technologies. It serves patients with moderate to profound hearing loss and operates globally, positioning itself as a leading provider in the hearing health and auditory implant market.
Average Trading Volume: 408,512
Technical Sentiment Signal: Sell
Current Market Cap: A$6.37B
Find detailed analytics on COH stock on TipRanks’ Stock Analysis page.